AstraZeneca’s Imfinzi shows promise in treating aggressive lung cancer
AstraZeneca (AZN.L), opens new tab said on Friday its blockbuster cancer drug Imfinzi helped improve… Read More
9 months ago
Imfinzi
Imfinzi and Imjudo: US approves lung cancer drugs
AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in… Read More
2 years ago
China approves AstraZeneca drug for lung cancer
China has approved AstraZeneca's drug Imfinzi to treat an aggressive type of lung cancer in… Read More
3 years ago